Dr Reddy's Laboratories Cash on Hand 2010-2024 | RDY
Dr Reddy's Laboratories cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Dr Reddy's Laboratories cash on hand for the quarter ending September 30, 2024 was $0.758B, a 8.34% decline year-over-year.
- Dr Reddy's Laboratories cash on hand for 2024 was $0.979B, a 27.64% increase from 2023.
- Dr Reddy's Laboratories cash on hand for 2023 was $0.767B, a 25.74% increase from 2022.
- Dr Reddy's Laboratories cash on hand for 2022 was $0.61B, a 24.49% increase from 2021.
Dr Reddy's Laboratories Annual Cash on Hand
(Millions of US $) |
| 2024 |
$979 |
| 2023 |
$767 |
| 2022 |
$610 |
| 2021 |
$490 |
| 2020 |
$356 |
| 2019 |
$363 |
| 2018 |
$325 |
| 2017 |
$284 |
| 2016 |
$606 |
| 2015 |
$650 |
| 2014 |
$568 |
| 2013 |
$415 |
| 2012 |
$357 |
| 2011 |
$130 |
| 2010 |
$226 |
| 2009 |
$ |
Dr Reddy's Laboratories Quarterly Cash on Hand
(Millions of US $) |
| 2024-09-30 |
$758 |
| 2024-06-30 |
$1,141 |
| 2024-03-31 |
$979 |
| 2023-12-31 |
$877 |
| 2023-09-30 |
$827 |
| 2023-06-30 |
$756 |
| 2023-03-31 |
$767 |
| 2022-12-31 |
$589 |
| 2022-09-30 |
$346 |
| 2022-06-30 |
$439 |
| 2022-03-31 |
$610 |
| 2021-12-31 |
$497 |
| 2021-09-30 |
$347 |
| 2021-06-30 |
$394 |
| 2021-03-31 |
$490 |
| 2020-12-31 |
$243 |
| 2020-09-30 |
$354 |
| 2020-06-30 |
$371 |
| 2020-03-31 |
$356 |
| 2019-12-31 |
$286 |
| 2019-09-30 |
$411 |
| 2019-06-30 |
$392 |
| 2019-03-31 |
$363 |
| 2018-12-31 |
$365 |
| 2018-09-30 |
$272 |
| 2018-06-30 |
$232 |
| 2018-03-31 |
$325 |
| 2017-12-31 |
$350 |
| 2017-09-30 |
$260 |
| 2017-06-30 |
$231 |
| 2017-03-31 |
$284 |
| 2016-12-31 |
$298 |
| 2016-09-30 |
$323 |
| 2016-06-30 |
$380 |
| 2016-03-31 |
$606 |
| 2015-12-31 |
$577 |
| 2015-09-30 |
$523 |
| 2015-06-30 |
$561 |
| 2015-03-31 |
$650 |
| 2014-12-31 |
$118 |
| 2014-09-30 |
$471 |
| 2014-06-30 |
$548 |
| 2014-03-31 |
$568 |
| 2013-12-31 |
$507 |
| 2013-09-30 |
$442 |
| 2013-06-30 |
$505 |
| 2013-03-31 |
$415 |
| 2012-12-31 |
$435 |
| 2012-09-30 |
$410 |
| 2012-06-30 |
$384 |
| 2012-03-31 |
$357 |
| 2011-12-31 |
$349 |
| 2011-09-30 |
$192 |
| 2011-06-30 |
$125 |
| 2011-03-31 |
$130 |
| 2010-12-31 |
$99 |
| 2010-09-30 |
$134 |
| 2010-06-30 |
$188 |
| 2010-03-31 |
$226 |
| 2009-12-31 |
$157 |
| 2009-09-30 |
$128 |
| 2009-06-30 |
$139 |
| 2009-03-31 |
$120 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$12.621B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
